Wired For Addiction™ is an international DNA company that looks at genetic variants linked to addiction and mood disorders. Utilizing their patent-pending custom genetic panel, they identify, isolate, and measure 85 biomarkers highly correlated to substance use disorders and mental health conditions.
Through Wired For Addiction’s remote sample collection process, patients are able to provide their specimen from the comfort of their home or treatment facility, thereby eliminating geographical and logistical barriers to care. Once the samples have been sent to the Wired For Addiction™ lab(s) via the prepaid postage contained in the kits, their DNA, neurotransmitters, and hormones are analyzed, interpreted, and configured into their unique Biomarker Evaluation Report. This report itemizes the results of their specimen, the clinical correlation associated with the findings, and the prescribed treatment protocol, if so desired.
In 2021, Wired For Addiction™ was contacted by a Florida mother who adopted a Florida female child, "born addicted to barbiturates and methadone," according to the mom. At the time of birth, the infant received an APGAR Score of one at one minute, three at three minutes, and five at five minutes. Five was her maximum score and suffered from months of withdrawal symptoms. She coded twice during the detox process, and upon discharge, displayed classic aberrant behaviors of a physiologically illicit drug dependent individual. These behaviors continued through age 6 at which time, Wired For Addiction™ was contacted. These behaviors included focus difficulty, mood problems, sleep issues, chronic pain, and problematic interpersonal relationships. The adopted mother requested her daughter undergo testing, and for a treatment protocol be created in an effort to optimize her daughter’s home, academic, and social life.
Wired For Addiction™ shipped the family the patent-pending custom genetic test kit to their home where the adopted mother collected her daughter’s samples according to the instructions included in the kit. The test kit was sent back to the lab utilizing the prepaid shipping label in the kit and the results were analyzed and interpreted by the assigned Wired For Addition™ clinician who went on to create the child’s Biomarker Evaluation Report and treatment protocol.
The assigned Wired For Addiction™ clinician, the adopted mother, and the child shared a virtual telehealth appointment to discuss the genetic findings, their correlation to the symptoms experienced by the child, and the prescribed treatment protocol. The family agreed to the treatment plan, the prescriptions were sent electronically to be filled, and the care commenced.
After following the prescribed treatment protocol for 6 months and maintaining bi-weekly telehealth visits to ensure adherence to the protocol, the child underwent a retest to evaluate the efficacy of her genetic-guided biochemical pathway support. As expected, the child not only experienced improved focus in school, better relationships in her home and social life, decreased physical pain, and improved sleep – her objective biomarkers supported those symptomatic improvements.
Seven of the 11 neurotransmitters and four of the four hormones measured in Wired For Addiction’s custom genetic panel were optimized. The heterozygous and homozygous single nucleotide polymorphisms revealed in the panel were supported leading to optimized biochemical pathways thereby reducing the correlated aberrant behaviors.
The current empirical model for diagnosing and prescribing individuals suffering from a mental health condition or substance use disorder lacks continuity and compromises care. Wired For Addictions’ patent-pending genetic panel identifies, isolates, and measures specific biomarkers requiring optimization for mental health. By determining the precise biochemical pathway(s) requiring support and the level to which support is required is what yields measurable and experiential improvement.
